Faculty of Medicine
Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14
Browse
10 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, SAFETY AND EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS IN PATIENTS WITH CHRONIC HEPATITIS C AND CHRONIC KIDNEY DISEASE(Macedonian Infectious Diseases Society, 2022-11); ; ;Gasheva, Magdalena; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Seroprevalence of HBV markers in medical students(Clinical Microbiology and Infection, 2004-05) ;Toshevski, Boban ;Ivanovski, Ljubomir ;Dimitriev, Dimitar ;Gasheva, MagdalenaGrunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, THE BEGINNING OF THE NEW ERA IN THE TREATMENT OF HCV INFECTION(Macedonian Medical Association, Macedonian Infectious Diseases Society, 2016-10) ;Gasheva, Magdalena ;Evtimovska, Cvetanka ;Toshevski, Boban; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Etiological aspects of chronic viral hepatitis(International Society for Infectious Diseases, 2004-03) ;Evtimovska,Cvetanka ;Dimitriev, Dimitar ;Gasheva, Magdalena ;Ivanovska, JulijanaGrunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Motivation of health care workers for Hepatitis B vaccination(International Society for Infectious Diseases, 2004-03) ;Gasheva, Magdalena ;Ivanovski, Ljubomir ;Dimitriev, Dimitar ;Evtimovska, CvetankaGrunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, HCV genotype prevalence among HCV infected i.v drug users in the Republic of Macedonia in 2004 and 2006(International Society for Infectious Diseases, 2006-06) ;Grunevska, Violeta ;Ivanovski, Ljubomir ;Dimitriev, Dimitar ;Nastevska, CvetankaGasheva, Magdalena - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Prediction of Early Virological Response-4 versus 12 weeks of Peginterferon alfa2a (40KD) plus Ribavirin Treatment in Chronic Hepatitis C patients(International Society for Infectious Diseases, 2006-06) ;Gasheva, Magdalena ;Ivanovski, Ljubomir ;Evtimovska, Cvetanka ;Grunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Adverse Events During Pegylated Interferon Ribavirin Combination Therapy in Patients with Chronic Hepatitis C(International Society for Infectious Diseases, 2006-06) ;Evtimovska,Cvetanka ;Ivanovski, Ljubomir ;Gasheva, Magdalena ;Grunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SAFETY AND EFFICACY OF SOFOSBUVIR BASED THERAPY IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION(Macedonian Infectious Diseases Society, 2022-11); ; ;Toshevski, Boban; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The clinical significance of quantitative HBSAG in patients with HBEAG negative chronic hepatitis B(University Clinical Centre Tuzla, 2019-09-17); ; ;Gasheva, Magdalena ;Toshevski, Boban<jats:p>Background: The quantification of HBsAg provides different and complementary information that helps in determination of the different phases of chronic hepatitis B viral infection, evaluation and follow-up of liver disease progression as well as in treatment individualization.Aim: To evaluate the clinical significance of quantitative HBsAg (qHBsAg) in patients with HBeAg negative chronic hepatitis (CHB) and its correlation with the serum levels of alanine aminotransferase (ALT), quantitative HBV DNA and liver fibrosis.Subjects and Methods: The study included 53 treatment naïve patients with HBeAg negative chronic hepatitis B. All patients underwent complete laboratory and serology testing, quantification of HBV DNA and HBs antigen. The liver stiffness was measured with elastography. Patients’ demographic characteristics, viral and biochemical markers were recorded at one point of time.Results: Correlation analysis between the qHBsAg and ALT showed an significant, positive correlation between the parameters for R=0.42 and p<0.05; there was statistically non-significant positive correlation for R=0.25 and p>0.05 between qHBsAg and HBV DNA. There was a positive correlation between qHBsAg and liver fibrosis for R=0.08 and p>0.05. The serum levels of HBsAg had greater impact on the serum levels of ALT compared to that of HBV DNA for R=0.15 and p>0.05.Conclusion: Patients with higher ALT values and higher liver fibrosis score have higher qHBsAg; qHBsAg can reflect the serum HBV DNA levels.</jats:p>
